Portfolio

AdheronTherapeutics

Adheron Therapeutics

Biotechnology company pioneering the development of a best in class antibody to Cadherin-11, tackling a variety of diseases by disrupting the adhesion of cells. Acquired by Roche in 2015

Ambit Biosciences

Ambit Biosciences

Biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications. Acquired by Daiichi Sankyo in 2014

Applied Genetic Technologies Corp.

Applied Genetic Technologies Corporation

Gene therapy company focused on the research and development of novel therapeutics for patients with unmet medical needs utilizing AGTC's proprietary, non-pathogenic adeno-associated virus (AAV) delivery system

Armaronbio

Armaron Biosciences

Armaron Biosciences Pty Ltd (formerly Neuprotect) is a life sciences start-up company based in Melbourne, Australia. Armaron is developing proprietary cardioprotectant and neuroprotectant small molecules to reduce tissue damage following a heart attack or stroke

Catabasis

Catabasis

Biopharmaceutical company dedicated to the discovery and development of innovative medicines to treat inflammatory and metabolic diseases

Cerapedics

Cerapedics

Spine-focused company developing a biological medical device for enhancement of cervical spine fusion

Corridor Pharmaceuticals

Corridor Pharmaceuticals

Biopharmaceutical company focused on arginase inhibition to restore effector function of T cells, with applications in cancer and IPF. Acquired by Astrazeneca in 2014

G1 Therapeutics

G1 Therapeutics

Biopharmaceutical company developing a novel small molecule-based method for preventing the hematological side effects of exposure to ionizing radiation and cancer chemotherapy

Inotek Pharmaceuticals

Inotek Pharmaceuticals

Biopharmaceutical firm focused on the development of innovative drug candidates to address significant diseases of the eye, with a major focus on glaucoma

VaxInnate

VaxInnate

Biotechnology company developing novel, proprietary vaccines for infectious diseases

VentiRx Pharmaceuticals

VentiRx Pharmaceuticals

Biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of cancer, respiratory, and autoimmune diseases

Xencor

Xencor

Biotechnology company that focuses on antibody engineering to significantly improve antibody half-life, immune-regulatory function and potency

The links in this section will take you to web sites maintained by third parties. All content on the third party sites is the responsibility of the owners of the sites, including protection of your privacy, which is governed by the privacy policy of those sites. We encourage you to read the Privacy Policy of every web site you visit.